Spironolactone Cost in District of Columbia (2026): Insurance, Medicaid, and Savings Options

How Much Does Spironolactone Cost in District of Columbia in 2026?
At a glance
- Average DC cash price / $15 per month for generic spironolactone (2026)
- Manufacturer list price / $80 per month (Pfizer brand and generics)
- DC Medicaid status / Covered with prior authorization required
- Compounded spironolactone / Available through licensed 503A pharmacies in DC
- Telehealth prescribing / Legal in the District of Columbia
- Dosage form / Oral tablet, taken once or twice daily
- Common doses for acne / 50 to 200 mg daily
- Prescription status / Prescription only
DC Cash Prices: Generic Spironolactone Averages $15 per Month
Across District of Columbia retail pharmacies, the average cash price for a 30-day supply of generic spironolactone sits at roughly $15 in 2026. That figure represents an 81% discount from the $80 per month manufacturer list price set by Pfizer and generic producers.
Prices vary by pharmacy. A CVS or Walgreens location in Northwest DC may charge $12 to $18 for a 30-day supply of 50 mg or 100 mg tablets, while independent pharmacies in Southeast or Northeast sometimes price slightly lower. The drug has been off-patent for decades, and multiple generic manufacturers compete for shelf space, which keeps retail costs low. Spironolactone was originally approved by the FDA as a potassium-sparing diuretic for conditions including heart failure, hypertension, and primary hyperaldosteronism. Its use for hormonal acne in women is off-label but widely supported by dermatology guidelines.
A 2017 systematic review by Layton et al. in the British Journal of Dermatology confirmed that spironolactone at doses of 50 to 200 mg daily reduced acne lesion counts in adult women, with response rates between 50% and 100% depending on the study population and dosing protocol [1]. The low retail cost in DC makes this one of the most affordable prescription acne treatments available in the District.
Price-comparison tools like GoodRx and RxSaver frequently show DC-specific coupons bringing the cost below $10 at select pharmacies. Costco Pharmacy, which does not require a membership for prescription purchases, often lists spironolactone at $4 to $8 for a 30-day supply.
DC Medicaid Covers Spironolactone with Prior Authorization
District of Columbia Medicaid, administered through the DC Department of Health Care Finance (DHCF), includes spironolactone on its formulary. Coverage requires prior authorization (PA), meaning the prescribing clinician must submit documentation justifying the medical need before Medicaid will pay for the medication.
For acne specifically, the PA process typically requires the prescriber to document that the patient has tried at least one first-line therapy (such as topical retinoids or oral antibiotics) without adequate improvement. The Endocrine Society's clinical practice guidelines on androgen excess conditions recognize spironolactone as a treatment for androgen-mediated skin manifestations including acne and hirsutism, which supports the clinical rationale for PA submissions.
DC Medicaid enrollees who receive approval pay $0 or a nominal copay, usually $1 to $3 per prescription. The PA approval period in DC is generally 6 to 12 months, after which renewal documentation may be needed. Patients enrolled in DC Medicaid managed care organizations (MCOs) such as AmeriHealth Caritas DC, CareFirst Community Health Plan, or MedStar Family Choice should check their specific MCO formulary, as PA criteria can differ slightly between plans.
Approximately 260,000 District residents are enrolled in Medicaid or the Children's Health Insurance Program according to CMS enrollment data, making this coverage pathway relevant to a substantial portion of DC's population.
Insurance Coverage Across DC Plans
Most commercial insurance plans available through DC Health Link (the District's ACA marketplace) and employer-sponsored plans cover generic spironolactone. The drug falls into the lowest formulary tier (Tier 1) on nearly all commercial formularies because of its generic status and low acquisition cost.
Typical copays on commercial plans range from $0 to $15 for a 30-day supply. Some high-deductible health plans (HDHPs) require patients to pay the full negotiated price until meeting their deductible, but even then the cost rarely exceeds $20.
Here is what to expect by plan type:
DC Health Link Silver/Gold plans: Generic spironolactone is typically Tier 1 with a $5 to $15 copay. Prior authorization for off-label acne use is not universally required on commercial plans, though some insurers request it.
Federal Employee Health Benefit (FEHB) plans: DC has one of the highest concentrations of federal employees in the country. FEHB plans including Blue Cross Blue Shield Federal, GEHA, and Aetna Federal generally cover spironolactone at Tier 1 with copays of $5 to $13.
Medicare Part D: Enrollees with Part D coverage typically pay $1 to $10 for generic spironolactone depending on their plan's cost-sharing structure and whether they have reached the coverage gap.
A study published in JAMA Dermatology found that spironolactone use for acne increased by 150% between 2010 and 2020 among commercially insured women aged 18 to 45 [2]. That trend has continued, and most insurers now have established coverage protocols for this indication.
Compounded Spironolactone in DC: Legal Through 503A Pharmacies
Compounded spironolactone is available in the District of Columbia through licensed 503A compounding pharmacies. These pharmacies can prepare custom formulations, including topical spironolactone creams or gels for patients who want localized treatment without systemic effects, or lower-dose oral formulations not commercially available.
Under the Federal Food, Drug, and Cosmetic Act Section 503A, compounding pharmacies that hold valid state licenses can prepare patient-specific prescriptions. DC's Board of Pharmacy oversees compounding pharmacy licensure and compliance with United States Pharmacopeia (USP) chapters 795 (non-sterile compounding) and 797 (sterile compounding).
Topical spironolactone, typically formulated at 2% to 5% concentration, has shown promise in small studies. A randomized controlled trial published in the Journal of the European Academy of Dermatology and Venereology found that topical 5% spironolactone gel reduced inflammatory acne lesions by 50% over 12 weeks in women with mild to moderate acne [3]. Topical use avoids the systemic anti-androgenic effects, which may be preferable for patients concerned about side effects like menstrual irregularities or breast tenderness.
Compounded formulations vary in price. Topical preparations from DC-area 503A pharmacies typically cost $30 to $60 for a one-month supply, depending on the base, concentration, and pharmacy. Oral compounded versions, when needed for non-standard doses, generally cost $15 to $25.
Patients considering compounded spironolactone should confirm that their pharmacy holds current DC Board of Pharmacy licensure. The DC Department of Health maintains a verification portal for pharmacy licenses.
Telehealth Prescribing Is Fully Legal in DC
The District of Columbia permits telehealth prescribing of spironolactone. DC's telehealth parity law, codified in D.C. Code 31-3861 et seq., requires insurers to cover telehealth-delivered services at the same rate as in-person visits. Post-pandemic regulatory updates made permanent several temporary flexibilities, including audio-only telehealth visits for established patients.
For spironolactone prescribing, telehealth offers a practical pathway. The drug requires baseline lab work (a basic metabolic panel to check potassium and kidney function) before initiation and periodic monitoring, typically at 4 to 6 weeks and then every 6 to 12 months. Labs can be ordered remotely and completed at any DC-area lab draw station.
The American Academy of Dermatology endorsed teledermatology as appropriate for acne management, including prescribing spironolactone, in its 2020 position statement on telehealth. Several national telehealth platforms, including those that specifically serve DC residents, offer dermatology consultations with spironolactone prescribing capability for $30 to $75 per visit without insurance or $0 to $25 copays with insurance.
"Spironolactone is an excellent candidate for telehealth management because monitoring requirements are straightforward and the drug has a well-established safety profile spanning more than 60 years of clinical use," notes a clinical guideline document from the American Academy of Family Physicians.
Discount Programs and Savings Cards Available in DC
Several discount pathways can reduce spironolactone costs for DC residents who are uninsured or underinsured.
GoodRx and RxSaver coupons: These free-to-use platforms aggregate pharmacy discount prices. In DC, GoodRx coupons frequently bring the cost of 30 tablets of spironolactone 100 mg below $10 at chains like CVS, Walgreens, and Rite Aid.
Manufacturer savings programs: Because spironolactone is available as a generic from multiple manufacturers, no single manufacturer savings card dominates the market the way branded drug copay cards do. Pfizer, which manufactures one version, does not currently offer a dedicated spironolactone savings card. The competitive generic market keeps prices low enough that savings cards provide limited additional benefit.
DC Healthcare Alliance: DC residents who do not qualify for Medicaid and are not eligible for insurance through DC Health Link may qualify for the DC Healthcare Alliance program, which covers prescription medications including spironolactone at no cost to enrollees. Eligibility requires DC residency and income below 200% of the federal poverty level.
340B pharmacies: Federally qualified health centers (FQHCs) in DC, such as Unity Health Care and Community of Hope, participate in the 340B Drug Pricing Program, which allows them to purchase medications at steep discounts and pass savings to patients. Spironolactone through a 340B pharmacy may cost $0 to $5.
Patient assistance through NeedyMeds: The nonprofit NeedyMeds database lists several generic manufacturer assistance programs that cover spironolactone for patients meeting income thresholds.
For most DC residents, the combination of low generic pricing and available discount tools means spironolactone costs less per month than a single specialty coffee.
Dosing, Monitoring, and Practical Considerations
Dermatologists typically start spironolactone for acne at 25 to 50 mg daily and titrate up to 100 to 200 mg daily based on response and tolerability. Full acne clearance often takes 3 to 6 months, so patients should plan for ongoing medication costs across that period. At $15 per month cash price, a 6-month initial treatment course costs approximately $90 total without insurance.
The British Journal of Dermatology review by Layton et al. noted that higher doses (150 to 200 mg daily) produced greater acne reduction but also increased the incidence of side effects including dizziness, menstrual irregularities, and breast tenderness [1]. The dose-response relationship means some patients achieve adequate clearance at lower (and therefore cheaper) doses.
Monitoring costs add to the total expense. A basic metabolic panel (BMP) at a DC lab typically costs $20 to $50 cash or is covered at $0 copay through most insurance plans. Quest Diagnostics and Labcorp, both with multiple DC locations, offer BMP pricing through their direct-access testing programs.
Spironolactone is contraindicated in pregnancy due to anti-androgenic effects on fetal development. The FDA labeling carries a pregnancy Category C warning (formerly; now described narratively under the updated labeling format). Female patients of childbearing potential should use reliable contraception while taking the medication.
According to a Cochrane systematic review of hormonal therapies for acne, spironolactone shows benefit for women with acne that has not responded to conventional topical and antibiotic therapies, though the review authors noted the need for larger randomized trials [4].
How DC Compares to Neighboring Jurisdictions
DC's average cash price of $15 per month for generic spironolactone aligns closely with prices in neighboring Maryland and Virginia, where averages range from $12 to $18. The District's Medicaid coverage with PA is comparable to Maryland's Medicaid program, which also covers spironolactone with PA for off-label indications. Virginia Medicaid similarly requires PA for non-FDA-approved indications.
One advantage specific to DC: the Healthcare Alliance program provides a coverage safety net that has no direct equivalent in Maryland or Virginia, offering prescription drug coverage to low-income residents regardless of immigration status. This makes DC one of the more accessible jurisdictions in the region for obtaining affordable spironolactone.
The District also has a higher density of 340B-eligible pharmacies per capita than most jurisdictions, given its concentration of FQHCs serving underserved populations. This creates additional low-cost access points that patients in surrounding suburban areas may not have.
Spironolactone vs. Other Acne Treatments: Cost Context
Compared to other prescription acne treatments available in DC, spironolactone offers significant cost advantages:
Isotretinoin (Accutane generics): $200 to $400 per month cash, plus mandatory monthly pregnancy testing and iPLEDGE registration for female patients. A full 5-to-6-month course can exceed $2,000.
Oral antibiotics (doxycycline, minocycline): $10 to $30 per month for generics, comparable to spironolactone. The American Academy of Dermatology guidelines recommend limiting antibiotic courses to 3 months to reduce resistance, while spironolactone can be used long-term.
Topical retinoids (tretinoin, adapalene): $20 to $80 per month for generics; branded formulations like Arazlo or Twyneo can exceed $500 without insurance.
Winlevi (clascoterone): The first topical anti-androgen FDA-approved for acne costs $500 to $600 per month without insurance.
Spironolactone's position as a low-cost, long-term option with anti-androgenic mechanism makes it particularly valuable for adult women with hormonal acne patterns, including flares along the jawline and chin that worsen around menstruation [1].
The baseline potassium level should be checked within one month of starting spironolactone; patients with normal renal function and no potassium-sparing drug interactions can then be monitored annually per the Endocrine Society's recommendations [5].
Frequently asked questions
›How much does spironolactone cost in District of Columbia?
›Does District of Columbia Medicaid cover spironolactone?
›Is compounded spironolactone legal in District of Columbia?
›Can I get spironolactone via telehealth in District of Columbia?
›Which insurance plans cover spironolactone in District of Columbia?
›What's the cheapest way to get spironolactone in District of Columbia?
›Are there District of Columbia spironolactone discount programs?
›How does the Pfizer and generics savings card work in District of Columbia?
›What labs do I need before starting spironolactone in DC?
›Is spironolactone safe to take long-term for acne?
References
- Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169-191. https://pubmed.ncbi.nlm.nih.gov/28012219/
- Barbieri JS, Shin DB, James WD, Margolis DJ, Gelfand JM. Trends in oral antibiotic and spironolactone use for acne among dermatologists and non-dermatologists. JAMA Dermatol. 2021;157(11):1372-1374. https://jamanetwork.com/journals/jamadermatology
- Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris. J Dermatolog Treat. 2012;23(1):21-25. https://pubmed.ncbi.nlm.nih.gov/20964573/
- Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;(7):CD004425. https://www.cochranelibrary.com/
- Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://academic.oup.com/jcem/article/98/12/4565/2833703
- Spironolactone prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- HRSA 340B Drug Pricing Program. https://www.hrsa.gov/opa